Navigation Links
Campbell Alliance Managed Markets Practice to Take Leadership Role at CBI's Formulary and Reimbursement Conference
Date:9/26/2007

RALEIGH, N.C., Sept. 26 /PRNewswire/ -- Campbell Alliance, the leading management consulting firm specializing in the pharmaceutical and biotechnology industries, today announced that its Managed Markets practice will be taking a leadership role at the 4th Annual Forum on Formulary and Reimbursement Strategies hosted by the Center for Business Intelligence (CBI). The conference will be held on September 27-28 at the Crown Plaza Valley Forge in King of Prussia, Pennsylvania.

Tony Lanzone, a Vice President at Campbell Alliance, will serve as conference chairperson. Mr. Lanzone has more than 15 years of experience in the healthcare industry, ranging from sales at a top-five pharmaceutical company to management consulting in both the hospital and pharmaceutical sectors. Prior to joining Campbell Alliance, he served as a senior director in Premier's HealthCare Informatics division. Mr. Lanzone earned his MBA from the Graduate School of Business at the College of William & Mary.

In addition, Mr. Lanzone and Steve Carter, Vice President in the Managed Markets practice at Campbell Alliance, will be facilitating a pre-conference workshop titled "Developing a Pricing and Reimbursement Strategy in an Evolving Payer Environment." Their presentation will focus on the importance of understanding the evolving reimbursement environment, and will provide an overview of payers and the role they play in the buying process for pharmaceuticals. The workshop will also review the key components of developing and executing strong payer strategies, including the potential product- and market-specific elements of a payer value proposition. During the workshop, participants will collaborate to develop an actual value proposition, contracting strategy, and pricing strategy in an interactive case study format.

Mr. Carter has provided consulting services to top pharmaceutical clients for more than a decade. His areas of expertise include pricing and contracting strategy, competitive assessment, research design, and analytical modeling. He holds a BS degree in Economics from the Massachusetts Institute of Technology.

For more information on CBI's Forum on Formulary and Reimbursement Strategies, please visit http://www.cbinet.com/show_conference.cfm?confCode=PC07074

About the Managed Markets Practice at Campbell Alliance

The Managed Markets practice at Campbell Alliance helps clients stay informed about changing conditions affecting the reimbursement and access landscape, understand the implications of these trends, and deal more effectively with third-party payers. Services include:

-- Market assessments utilizing quantitative and qualitative research and

analysis as well as decision-support modeling and scenario planning

-- Strategy development for key managed markets channels such as the

creation of value propositions and pricing and contracting strategies

-- Tactical execution including account segmentation and prioritization

About Campbell Alliance

Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industries. The firm's clients include most of the world's top 20 pharmaceutical companies, as well as numerous emerging and midsize firms. Campbell Alliance is organized into practice areas, each specializing in a critical industry function, including Brand Management, Business Development, Clinical Development, Managed Markets, and Sales. From its locations in Raleigh, N.C., Parsippany, N.J., Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, and Atlanta, the firm serves clients throughout North America, Europe, and Japan. For more information on Campbell Alliance, please visit http://www.campbellalliance.com.

James Forte

Director, Public and Media Relations

Campbell Alliance

919-844-7100, extension 7195

jforte@campbellalliance.com


'/>"/>
SOURCE Campbell Alliance
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Biomedical Alliance about more than stem cells
2. Doyle seeks $2.5M for biomedical alliance
3. Alliance looks to create the right chemistry in SE Wisconsin
4. Biomedical alliance marks first full year
5. New alliance to provide Wi-Fi network for City of Madison
6. Budget axe could cut SE Wisconsin tech alliance funding
7. Biotech Alliance pushes ahead in SE Wisconsin with likely state funding
8. Milwaukee research alliance sees need for incubator
9. University alliance gets $2.5 million to encourage minorities in science and technology
10. Suite Scheduler Announces Alliance with Ice Technologies
11. Alliance Brings E-Business Technologies to Wisconsin Manufacturers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):